Navigation Links
Silibinin, found in milk thistle, protects against UV-induced skin cancer
Date:1/30/2013

A pair of University of Colorado Cancer Center studies published this month show that the milk thistle extract, silibinin, kills skin cells mutated by UVA radiation and protects against damage by UVB radiation thus protecting against UV-induced skin cancer and photo-aging.

"When you have a cell affected by UV radiation, you either want to repair it or kill it so that it cannot go on to cause cancer. We show that silibinin does both," says Rajesh Agarwal, PhD, co-program leader of Cancer Prevention and Control at the CU Cancer Center and professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.

The first study, published in the journal Photochemistry and Photobiology worked with human skin cells subjected to UVA radiation, which makes up about 95 percent of the sun's radiation that reaches Earth. The Agarwal Lab treated these UVA-affected cells with silibinin. With silibinin, the rate at which these damaged cells died increased dramatically.

"When you take human skin cells keratinocytes and treat them with silibinin, nothing happens. It's not toxic. But when you damage these cells with UVA radiation, treatment with silibinin kills the cells," Agarwal says, thus removing the mutated cells that can cause skin cancer and photo-aging.

Specifically, the study shows that pretreatment with silibinin resulted in higher release of reactive oxygen species (ROS) within the UVA-exposed cells, leading to higher rates of cell death.

The second study, published this month by the same authors in the journal Molecular Carcinogenesis shows that instead of beneficially killing cells damaged by UVA radiation, treatment with silibinin protects human skill cells from damage by UVB radiation, which makes up about 5 percent of the sun's radiation reaching Earth.

Again, remember Agarwal's suggestion that the prevention of UV-induced skin cancer can happen in two ways: by protecting against DNA damage or by killing cells with damaged DNA. With UVA, silibinin kills; with UVB, it protects, in this case by increasing cells' expression of the protein interleukin-12, which works to quickly repair damaged cells.

"It has been 20 years of work with this compound, silibinin," Agarwal says. "We first noticed its effectiveness in treating both skin and solid cancers, and we now have a much more complete picture of the mechanisms that allow this compound to work."

Agarwal and colleagues continue to test the effectiveness of silibinin in cancer prevention and treatment in cell lines and mouse models, and are working toward human trials of silibinin-based therapeutics.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. Brainwave balancing research receives $1 million grant from The Susanne Marcus Collins Foundation
2. Marina Aleksintser, Founder of BikiniMommyOnline & JNL Fitness Model Factory West Coast President, Brings the Hottest Method of Training to Los Angeles
3. The Prospero Foundation Supports a Dentist in Azerbaijan
4. Personal epigenetic signatures found consistent in prostate cancer patients metastases
5. Announcing the Release of the Michigan Lupus Foundation 2012 Annual Report
6. The HearStrong Foundation Launches Nationwide to Acknowledge the Accomplishments of Those with Hearing Loss
7. YogaFit’s Founder Beth Shaw Named to LIU Post College of Management Advisory Board
8. The Prospero Foundation Supports a Medical Clinic in Uganda
9. New Dental Hygiene Floss Recommendations - Midtown Dentistry Found Research that Shows New Irrigation Devices as Good as Flossing
10. Push to Walk Receives Grant from the Kessler Foundation
11. Co-Founder of Omega3 Innovations Says Today’s Fish Oil Industry is on the Wrong Track, Sets Up Blog to Help Consumers Understand Why
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Atlanta, GA (PRWEB) , ... December 07, 2016 , ... ... en route to respond to an emergency medical call when he lost control of ... injuries. After being extricated from his vehicle, he was transported to Atlanta Medical Center, ...
(Date:12/7/2016)... ... , ... Castle Dermatology Institute is now offering liquid facelifts with Sculptra ... to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, San Fernando Valley ... rejuvenate and renew the facial appearance. , Sculptra is a highly effective injectable ...
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
(Date:12/7/2016)... ... ... it came time to blow out his candles on his 14th birthday, Estefano Reano had ... team at Joe DiMaggio Children’s Hospital surprised his family with a phone call that ... , “He was playing at home, when we got the phone call telling us ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and ... who needs treatment for a brain tumor. , Jason Bauer and his family ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... MOINES, Iowa , Dec. 8, 2016 /PRNewswire/ ... a pharmaceutical company advancing technologies designed to address ... appointment of Chitra Edwin , Ph.D., RAC, ... Compliance. Dr. Edwin will provide leadership for all ... for regulatory approvals, preparation of regulatory submissions, serving ...
(Date:12/7/2016)... 7, 2016 KEY FINDINGS ... such as reducing loss of blood during surgeries, ... arrests, rapid recovery after surgeries, and decreasing risks ... segmented into convective warming system, surface warming systems, ... reduce the stay at hospitals thus, lowering the ...
(Date:12/7/2016)... , Dec 7, 2016 Research and Markets ... and End User - Global Forecast to 2021" report to their ... , , ... 2.12 Billion by 2021, growing at a CAGR of 7.3% during the ... the growing prevalence of cancer and rapidly increasing geriatric population across the ...
Breaking Medicine Technology: